JAMA 293:1609–1616PubMedCrossRef 7. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D’Agostino RB, Gaziano JM (2007) Relations of serum phosphorus

and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879–885PubMedCrossRef 8. Tonelli M, Curhan G, CH5183284 mw Pfeffer M, Sacks F, Thadhani R, Melamed ML, Wiebe N, Muntner P (2009) Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120:1784–1792PubMedCrossRef 9. Larsson TE, Olauson Ro 61-8048 mouse H, Hagstrom E, Ingelsson E, Arnlov J, Lind L, Sundstrom J (2010) Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler this website Thromb Vasc Biol 30:333–339CrossRef 10. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL (1993) Determination

of vitamin D status by radioimmunoassay with an 125I-labelled tracer. Clin Chem 39:529–533PubMed 11. Bates CJ, Carter GD, Mishra GD, O’Shea D, Jones J, Prentice A (2003) In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteoporos Int 14:152–159PubMed 12. Barth J, Fiddy J, Payne R (1996) Adjustment of serum total calcium for albumin concentration: effects of non-linearity and of regression differences between laboratories. Ann Clin Biochem 33:55–58PubMed 13. Kannel WB (2002) Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 11:101–107PubMedCrossRef 14. de Ruijter W, Westendorp RGJ, Assendelft WJJ, den Elzen WPJ, de Craen AJM, le Cessie S, Gussekloo J (2009) Use of Framingham risk score and new biomarkers to predict Rolziracetam cardiovascular mortality in older people: population based observational cohort study. BMJ 338:a3083PubMedCrossRef

15. Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ (2004) Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89:5477–5481PubMedCrossRef 16. Jia X, Aucott LS, McNeill G (2007) Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr 98:593–599PubMedCrossRef 17. Autier P, Gandini S (2007) Vitamin D supplementation and total mortality. A meta-analysis of randomized controlled trials. Arch Intern Med 167:1730–1737PubMedCrossRef 18. Melamed ML, Michos ED, Post W, Astor B (2008) 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637PubMedCrossRef 19.